Quote  |  Bullboard  |  News  |  Opinion  |  Level II  |  Charts  |  Profile  |  Financials  |  Options  |  Price History

Cipher Pharmaceuticals Inc T.DND

Sector: Healthcare | Sub-Sector: Drug Manufacturers - Specialty & Generic
Alternate Symbol(s): CPHMF

Cipher Pharmaceuticals Inc. is a specialty commercial stage pharmaceutical company. It focuses on development and commercialization of novel formulations of currently marketed molecules using advanced drug delivery technologies.
Price: $7.63 | Change: +$0.01 | % Change: +0.13%
Volume: 4,981 | Day High/Low: 7.68/7.58 | 52 Week High/Low: 9.59/3.56

View modes: 
0 stars

Looks like no more sellers at these prices

All the weak hands must be gone at this level. Cipher may now see a break out to the up side. only 705 shares sold by 12 noon today.  rate and reply
0 stars

RE:RE:symetrical triangle

since the stock came from lower prices last summer before the big move that would make it a bullish triangle wouldn't it?....I'm betting on a breakout to the upside.  rate and reply
0 stars

RE:symetrical triangle

Very observant. I am very good at T.A. The pattern is not conclusive yet. A close above $7.93 with volume is a go. A close below $7.10 with volume ( and even without too much volume), not so good...read more
0 stars

symetrical triangle

I just noticed the chart....isn't that a bullish symmetrical chart? and aren't we at the tip of that triangle...signaling a big move shortly ahead? I'm not a big tech. analysis guy so anyone out there...read more
2.5 stars

RE:Yeah Ranbaxy does not care about Absorbica what ?????

oh and who said Ranbaxy doesn't care about Aborica, do you have a link for that?  rate and reply
2.5 stars

RE:Yeah Ranbaxy does not care about Absorbica what ?????

well the cat is out, I never said I put you on ignore, but you said you put me on ignore, yet then how did you and were able to see my top ten comment? In your own words the board has spoken you are...read more
0 stars

Yeah Ranbaxy does not care about Absorbica what ?????

Ranbaxy drugs sold in the United States will be gradually rebranded as Sun Pharma. Well if Sun Pharma does not care about Absorbica as you say then maybe they will just give all the rights to Cipher...read more
4 stars

As of Apr 04 2014 the consensus Cipher forecast amongst 3

[  As of Apr 04  2014 the consensus Cipher forecast amongst 3 polled investment analysts covering Cipher Pharmaceutical with link   http://markets.ft.com/research/Markets/Tearsheets/Forecasts?s=DND...read more
2 stars

RE:RE:RE:RE:Sun Pharmaceuticals could buy Cipher as well

…Absorica… Total net Absorica revenues in the third quarter 2013 were $4.5 million, comprised of $0.5 million in amortization of upfront licensing fee and $4.0 million in royalties on U.S. sales at...read more
5 stars

Doug Loe’s Top Healthcare and Biotech Picks for 2014

[http://www.cantechletter.com/2014/01/doug-loes-top-healthcare-biotech-picks-2014/ Doug Loe’s Top Healthcare and Biotech Picks for 2014 January 28, 2014 By Douglas Loe 1 Comment   Robust...read more
5 stars

RE:RE:RE:Sun Pharmaceuticals could buy Cipher as well

I don't really get your question. if Sun were interested in the international markets they would work out a royalty deal similar to what they did for the U.S.  No need to buy the company though. I...read more
4 stars

RE:RE:Sun Pharmaceuticals could buy Cipher as well

Where does it say that Ranbaxy is free to sell Absorbica and pay Cipher nothing for international markets not assigned for example in Europe / Japan South America / India / anywhere etc.  Can you...read more
3 stars

RE:Sun Pharmaceuticals could buy Cipher as well

Idle speculation and highly unlikely.  I would bet heavily against this happening.  Sun is free to  make licensing deals for the many international markets not assigned.   No  need to get involved in...read more
0 stars

Sun Pharmaceuticals could buy Cipher as well

[Sun Pharmaceuticals of India who just bought Ranbaxy may buy Cipher as well. Cipher is an easy buyout target because so many shares held by so few. A Cipher buyout is a much smaller buy then what...read more
0 stars

RE:Rehash of what's important- so whats not to like?

Good for you some truthful facts. How about the link as well? You forgot to rate your own post as 5 out of 5 as you do most of the time and not just on this board. I guess this means you are back full...read more
2.5 stars

Rehash of what's important- so whats not to like?

Just to give a go-over as to why I invested in DND,and most of this is readily available of course... The latest news from DND was:revenue up,EBITDAI up,net income up,money in the bank so no real debt...read more
0 stars

Spike 179 ignores and still the champ

You keep saying you will put me on ignore with all of your IDs yet you still keep trying to contradict my factual posts with disinformation. We all know you will never put me on ignore with all of...read more
2.5 stars

Truthseeker biggest Liar = Time to Ignore

Seems he twist every comment....I believe it was an analyst that said The derm section of Ranbaxy was a motivating factor. Not Sun Pharma.  rate and reply
0 stars

RE:RE:RE:looks like we have a new partner

Wrong check valucats "merger presentation" They do mention Ranbaxy's strength in derm and "acne" specifically this means Absorbica. A great and truthful post with facts unlike your attempt at more...read more
2 stars

RE:RE:looks like we have a new partner

no where in the article or even DND's press release does it mention that the sale was for Absorica sales or value. for $3.2-billion, betting it can fix factory quality glitches that plagued the...read more